| Literature DB >> 25151260 |
Tanushree Banerjee1, Deidra C Crews, Donald E Wesson, Anca Tilea, Rajiv Saran, Nilka Rios Burrows, Desmond E Williams, Neil R Powe.
Abstract
BACKGROUND: Diet can markedly affect acid-base status and it significantly influences chronic kidney disease (CKD) and its progression. The relationship of dietary acid load (DAL) and CKD has not been assessed on a population level. We examined the association of estimated net acid excretion (NAE(es)) with CKD; and socio-demographic and clinical correlates of NAE(es).Entities:
Mesh:
Year: 2014 PMID: 25151260 PMCID: PMC4151375 DOI: 10.1186/1471-2369-15-137
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Figure 1Summary of reasons for participant exclusion from study population.
Characteristics of study participants by estimated Net Acid Excretion quintiles
| Age category (in years), (%) | | | | | | <0.0001 |
| 20– < 40 | 717 (29.2) | 834 (33.9) | 845 (34.4) | 887 (36.1) | 1122 (45.6) | |
| 40– < 60 | 776 (31.6) | 654 (26.6) | 719 (29.2) | 758 (30.8) | 774 (31.5) | |
| 60– < 70 | 447 (18.2) | 406 (16.5) | 380 (15.4) | 385 (15.7) | 292 (11.9) | |
| ≥70 | 517 (21.0) | 565 (23.0) | 516 (21.0) | 429 (17.4) | 270 (10.9) | |
| Age, continuous (mean ± SD) | 47.1 ± 0.50 | 46.7 ± 0.61 | 46.9 ± 0.64 | 45.9 ± 0.48 | 42.9 ± 0.44 | 0.001 |
| Gender, (%) | | | | | | <0.0001 |
| Male | 879 (35.8) | 1246 (50.7) | 1407 (57.2) | 1477 (60.1) | 1442 (58.7) | |
| Female | 1579 (64.2) | 1213 (49.3) | 1053 (42.8) | 982 (39.9) | 1015 (41.3) | |
| Race/Ethnicity, % | | | | | | <0.0001 |
| Non-Hispanic Blacks | 381 (17.0) | 342 (15.0) | 395 (17.5) | 458 (20.1) | 639 (28.3) | |
| Mexican Americans | 468 (20.9) | 488 (21.4) | 564 (25.0) | 615 (27.1) | 685 (30.3) | |
| Non-Hispanic Whites | 1390 (62.1) | 1450 (63.6) | 1298 (57.5) | 1201 (52.8) | 937 (41.4) | |
| Poverty Income Ratio, % | | | | | | <0.0001 |
| ≤2 | 848 (37.2) | 880 (39.0) | 923 (41.2) | 1101 (48.4) | 1228 (54.9) | |
| 2– ≤ 3 | 389 (17.1) | 335 (14.9) | 386 (17.2) | 338 (14.8) | 365 (16.3) | |
| 3– ≤ 4 | 278 (12.2) | 326 (14.5) | 315 (14.0) | 268 (11.8) | 229 (10.3) | |
| >4 | 762 (33.5) | 713 (31.6) | 618 (27.6) | 570 (25.0) | 413 (18.5) | |
| Education History, % | | | | | | 0.002 |
| <High School | 563 (22.9) | 637 (25.9) | 727 (29.6) | 841 (34.3) | 1104 (44.9) | |
| High School/Some College | 1308 (53.3) | 1269 (51.6) | 1225 (50.0) | 1201 (48.9) | 1084 (44.2) | |
| >College | 583 (23.8) | 551 (22.5) | 500 (20.4) | 413 (16.8) | 267 (10.9) | |
| Smoker, % | | | | | | 0.004 |
| Current | 570 (23.2) | 527 (21.4) | 456 (18.5) | 511 (20.8) | 594 (24.2) | |
| Past | 647 (26.4) | 695 (28.3) | 689 (28.0) | 664 (27.1) | 607 (24.7) | |
| Never | 1236 (50.4) | 1235 (50.3) | 1315 (53.5) | 1280 (52.1) | 1253 (51.1) | |
| Diabetes, % | | | | | | 0.11 |
| Yes | 284 (11.5) | 298 (12.1) | 305 (12.4) | 302 (12.3) | 254 (10.3) | |
| No | 2175 (88.5) | 2160 (87.9) | 2155 (87.6) | 2157 (87.7) | 2203 (89.7) | |
| Hypertension, % | | | | | | 0.27 |
| Yes | 855 (34.8) | 864 (35.2) | 845 (34.3) | 824 (33.5) | 731 (29.8) | |
| No | 1604 (65.2) | 1594 (64.8) | 1615 (65.7) | 1635 (66.5) | 1726 (70.2) | |
| Cardiac Disease, % | | | | | | 0.005 |
| Yes | 367 (15.0) | 296 (12.1) | 279 (11.4) | 220 (9.0) | 182 (7.4) | |
| No | 2078 (85.0) | 2146 (87.9) | 2172 (88.6) | 2231 (91.0) | 2267 (92.6) | |
| Total Caloric Intake, % | | | | | | <0.0001 |
| <2000 Kcal/day | 2172 (88.4) | 1669 (67.9) | 1068 (43.4) | 613 (24.9) | 322 (13.1) | |
| ≥2000 Kcal/day | 286 (11.6) | 790 (32.1) | 1392 (56.6) | 1846 (75.1) | 2135 (86.9) | |
Poverty Income Ratio = a ratio of family income to poverty threshold.
HTN = Hypertension defined as self-reported, avg BP > 140/90 or use of medications.
Diabetes defined as self-reported or hemoglobin A1c (A1c) ≥ 6.5%.
*By X2test for categorical variables and one-way ANOVA for continuous variables.
Figure 2Frequency distribution of estimated Net Acid Excretion (from 24-hr dietary recall) in 12,293 NHANES (1999–2004) participants, median value (IQR) =55.15 (40.92, 71.07).
Figure 3Distribution by the quintiles of estimated Net Acid Excretion of (a) Median Urinary Albumin-to-Creatinine Ratio (ACR) (b) Mean eGFR (c) Prevalence of CKD Adults in each Stage.
Relationship of estimated Net Acid Excretion with Albuminuria, Kidney Dysfunction, and CKD Stages and Risk Groups in NHANES participants (N = 11,285)
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 1.39 (1.09–1.78) | 1.29 (0.98–1.70) | 1.47 (1.11–1.95) | 0.92 (0.76–1.11) |
| Quintile 3 | 1.33 (1.08–1.63) | 1.84 (1.38–2.45) | 1.79 (1.36–2.37) | 1.30 (1.08–1.57) |
| Quintile 4 | 1.44 (1.15–1.80) | 2.35 (1.78–3.12) | 2.23 (1.63–3.05) | 1.65 (1.41–1.93) |
| Quintile 5 | 1.71 (1.40–2.07) | 2.63 (2.07–3.34) | 2.51 (1.73–3.64) | 1.99 (1.67–2.37) |
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 1.25 (0.80–1.94) | 1.13 (0.89–1.44) | 0.94 (0.52–1.70) | 0.75 (0.60–0.94) |
| Quintile 3 | 1.36 (1.04–1.78) | 1.06 (0.82–1.36) | 1.10 (0.74–1.65) | 0.92 (0.74–1.15) |
| Quintile 4 | 1.27 (0.98–1.66) | 1.17 (0.86–1.58) | 1.23 (0.91–1.65) | 1.08 (0.88–1.29) |
| Quintile 5 | 1.57 (1.20–2.05) | 1.37 (0.91–2.05) | 1.20 (0.87–1.62) | 1.10 (0.91–1.30) |
| 0.04 | 0.04 | 0.05 | 0.01 |
Quintile 1: min to 37.35 mEq/day; Quintile 2: >37.35 to 49.62 mEq/day; Quintile 3: >49.62 to 60.89 mEq/day; Quintile 4: >60.89 to 75.65 mEq/day; Quintile 5: >75.65 to max mEq/day.
+UACR- Urinary albumin to creatinine ratio.
#CKD Stages defined by KDOQI Classification.
@CKD Risk Groups defined by KDIGO Nomenclature.
*Adjustment for demographics (age, gender and race/ethnicity), socio-economic status (education, poverty income ratio), body mass index, risk factors (smoking, diabetes, hypertension, self-reported cardio-vascular diseases [CVD i.e. (coronary heart disease, congestive heart failure or stroke)]), total caloric intake, and body mass index.
OR (95% CI) = Odds Ratio (95% confidence interval).
$From multiple logistic regression.
**From ordinal logistic regression.
Relationship of estimated Net Acid Excretion with Albuminuria, Kidney Dysfunction, and CKD Stages and Risk Groups in participants with hypertension but without diabetes (N = 3,204)
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 0.87 (0.53, 1.44) | 1.38 (0.71, 2.31) | 1.02 (0.75–1.40) | 0.94 (0.70–1.28) |
| Quintile 3 | 0.83 (0.53, 1.28) | 1.57 (0.99, 2.49) | 1.37 (0.89–2.11) | 1.32 (0.94–1.86) |
| Quintile 4 | 1.07 (0.65, 2.15) | 2.21 (1.38, 3.55) | 1.64 (1.12–2.39) | 1.58 (1.12–2.23) |
| Quintile 5 | 1.30 (1.02, 2.27) | 2.02 (1.31, 3.12) | 2.51 (1.74–3.61) | 2.22 (1.54–3.21) |
| 0.02 | 0.02 | 0.001 | <0.0001 | |
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 0.94 (0.49–1.80) | 1.43 (0.96–2.14) | 0.65 (0.58–1.14) | 0.75 (0.55–1.02) |
| Quintile 3 | 1.47 (0.75–2.85) | 1.59 (0.96–2.63) | 1.00 (0.60–1.58) | 0.98 (0.65–1.41) |
| Quintile 4 | 1.11 (0.69–1.76) | 1.75 (0.92–3.31) | 0.79 (0.43–1.30) | 0.81 (0.55–1.20) |
| Quintile 5 | 1.31 (0.90–1.91) | 1.75 (1.11–2.75) | 1.11 (0.56–2.91) | 1.00 (0.61–1.55) |
| 0.04 | 0.01 | 0.10 | 0.08 |
Quintile 1: min to 37.35 mEq/day; Quintile 2: >37.35 to 49.62 mEq/day; Quintile 3: >49.62 to 60.89 mEq/day; Quintile 4: >60.89 to 75.65 mEq/day; Quintile 5: >75.65 to max mEq/day.
+UACR- Urinary albumin to creatinine ratio.
# CKD Stages defined by KDOQI Classification.
@CKD Risk Groups defined by KDIGO Nomenclature.
*Adjustment for demographics (age, gender and race/ethnicity), socio-economic status (education, poverty income ratio), body mass index, and risk factors (smoking, diabetes, hypertension, self-reported cardio-vascular diseases [CVD i.e. (coronary heart disease, congestive heart failure or stroke)]), total caloric intake, and body mass index.
OR (95% CI) = Odds Ratio (95% confidence interval).
$From multiple logistic regression.
**From ordinal logistic regression.
Relationship of estimated Net Acid Excretion with Albuminuria, Kidney Dysfunction, and CKD Stages and Risk Groups in participants without hypertension and without diabetes (n = 6,772)
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 1.12 (0.77, 1.64) | 1.26 (0.93, 1.69) | 1.57 (1.11–2.22) | 0.96 (0.75–1.23) |
| Quintile 3 | 1.62 (1.09, 2.39) | 1.79 (1.23, 2.59) | 1.88 (1.22–2.90) | 1.64 (1.34–2.01) |
| Quintile 4 | 1.57 (1.16, 2.14) | 2.09 (1.46, 2.99) | 3.29 (2.06–5.27) | 1.93 (1.51–2.46) |
| Quintile 5 | 1.79 (1.21, 2.65) | 2.52 (1.80, 3.52) | 3.51 (1.94–6.36) | 2.99 (2.29–3.88) |
| 0.04 | <0.0001 | <0.0001 | <0.0001 | |
| | | | | |
| Quintile 1 | Reference | Reference | Reference | Reference |
| Quintile 2 | 0.96 (0.58–1.58) | 0.82 (0.44–1.51) | 1.26 (0.66–2.40) | 0.77 (0.55–1.06) |
| Quintile 3 | 1.23 (0.80–1.88) | 0.85 (0.58–1.25) | 1.27 (0.70–2.31) | 1.03 (0.77–1.37) |
| Quintile 4 | 1.09 (0.72–1.63) | 1.07 (0.78–1.45) | 1.13 (0.72–1.78) | 0.90 (0.63–1.28) |
| Quintile 5 | 1.58 (1.04–2.39) | 1.42 (1.07–2.10) | 1.41 (0.92–2.16) | 1.12 (0.75–1.67) |
| 0.05 | 0.01 | 0.06 | 0.07 |
Quintile 1: min to 37.35 mEq/day; Quintile 2: >37.35 to 49.62 mEq/day; Quintile 3: >49.62 to 60.89 mEq/day; Quintile 4: >60.89 to 75.65 mEq/day; Quintile 5: >75.65 to max mEq/day.
+UACR- urinary albumin to creatinine ratio.
#CKD Stages defined by KDOQI Classification.
@CKD Risk Groups defined by KDIGO Nomenclature.
*Adjustment for demographics (age, gender and race/ethnicity), socio-economic status (education, poverty income ratio), body mass index, and risk factors (smoking, diabetes, hypertension, self-reported cardio-vascular diseases [CVD i.e. (coronary heart disease, congestive heart failure or stroke)]), total caloric intake, and body mass index.
OR (95% CI) = Odds Ratio (95% confidence interval).
$From multiple logistic regression.
**From ordinal logistic regression.
Figure 4Association of NHANES (1999–2004) Participant Characteristics with estimated Net Acid Excretion (NAE). The graph shows adjusted beta coefficients, from quintile (median) regression. Points show beta coefficients per quintile, and bars show 95% confidence intervals. Reference groups (Dots on the vertical line = 0) are not shown for clarity.